| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | TRERF1 NCOA2 KMT2D YAP1 MED12L WWTR1 MAML2 CREBBP MAML3 EP300 | 1.53e-08 | 303 | 58 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 NCOA2 HDAC4 FOXP2 YAP1 ARID2 MED12L FOXP1 RORC BTAF1 CREB1 CREBBP EP300 STAT3 | 2.27e-08 | 753 | 58 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 NCOA2 KMT2D HDAC4 YAP1 MED12L WWTR1 BTAF1 MAML2 CREBBP MAML3 EP300 | 6.02e-08 | 562 | 58 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.60e-07 | 140 | 58 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 4.92e-07 | 54 | 58 | 5 | GO:0001223 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 NCOA2 KMT2D HDAC4 YAP1 SGTA EPC1 MED12L GIGYF2 WWTR1 BTAF1 MAML2 CREBBP MAML3 EP300 STAT3 | 9.82e-07 | 1356 | 58 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.98e-06 | 417 | 58 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 NCOA2 KMT2D HDAC4 YAP1 EPC1 MED12L WWTR1 BTAF1 MAML2 CREBBP MAML3 EP300 STAT3 | 4.21e-06 | 1160 | 58 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TRERF1 NCOA2 HDAC4 FOXP2 YAP1 FOXP1 CREB1 CREBBP EP300 STAT3 | 6.06e-06 | 582 | 58 | 10 | GO:0140297 |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 8.29e-06 | 2 | 58 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 8.29e-06 | 2 | 58 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 8.29e-06 | 2 | 58 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.68e-05 | 187 | 58 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 2.48e-05 | 3 | 58 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 2.48e-05 | 3 | 58 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.56e-05 | 20 | 58 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.98e-05 | 21 | 58 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.79e-05 | 320 | 58 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.27e-05 | 326 | 58 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX6 NCOA2 FOXP4 HDAC4 FOXP2 YAP1 MITF FOXP1 RORC CREB1 SOX13 EP300 STAT3 | 4.54e-05 | 1244 | 58 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX6 NCOA2 FOXP4 HDAC4 FOXP2 YAP1 MITF FOXP1 RORC CREB1 CREBBP SOX13 EP300 STAT3 | 5.56e-05 | 1459 | 58 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX6 NCOA2 FOXP4 HDAC4 FOXP2 YAP1 MITF FOXP1 RORC CREB1 SOX13 EP300 STAT3 | 5.66e-05 | 1271 | 58 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.19e-04 | 33 | 58 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.60e-04 | 739 | 58 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone modifying activity | 5.31e-04 | 229 | 58 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 5.31e-04 | 229 | 58 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 8.50e-04 | 15 | 58 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | proteasome binding | 1.52e-03 | 20 | 58 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | proline-rich region binding | 1.68e-03 | 21 | 58 | 2 | GO:0070064 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.88e-03 | 84 | 58 | 3 | GO:0003684 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 2.27e-03 | 1205 | 58 | 10 | GO:0046983 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 5.17e-03 | 37 | 58 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 6.99e-03 | 1412 | 58 | 10 | GO:0000981 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 7.25e-03 | 44 | 58 | 2 | GO:0140938 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 SOX6 NCOA2 KMT2D HDAC4 YAP1 ASXL3 ARID2 EPC1 MITF MED12L FOXP1 WWTR1 MAML2 CREB1 CREBBP MAML3 EP300 STAT3 | 5.10e-09 | 1390 | 59 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TRERF1 SOX6 NCOA2 FOXP4 HDAC4 FOXP2 YAP1 EPC1 MITF FOXP1 RORC WWTR1 BTAF1 ERN2 CREB1 CREBBP SOX13 EP300 STAT3 | 5.67e-09 | 1399 | 59 | 19 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TRERF1 SOX6 NCOA2 FOXP4 HDAC4 FOXP2 YAP1 EPC1 MITF FOXP1 RORC WWTR1 BTAF1 ERN2 CREB1 CREBBP SOX13 EP300 STAT3 | 6.67e-09 | 1413 | 59 | 19 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX6 NCOA2 FOXP4 HDAC4 FOXP2 YAP1 EPC1 MITF FOXP1 RORC WWTR1 CREBBP SOX13 EP300 STAT3 | 1.82e-07 | 1053 | 59 | 15 | GO:0000122 |
| GeneOntologyBiologicalProcess | lung epithelium development | 8.48e-07 | 61 | 59 | 5 | GO:0060428 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 3.94e-06 | 83 | 59 | 5 | GO:0010569 | |
| GeneOntologyBiologicalProcess | lung cell differentiation | 6.23e-06 | 42 | 59 | 4 | GO:0060479 | |
| GeneOntologyBiologicalProcess | lung epithelial cell differentiation | 6.23e-06 | 42 | 59 | 4 | GO:0060487 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 7.52e-06 | 44 | 59 | 4 | GO:1905168 | |
| GeneOntologyBiologicalProcess | negative regulation of lung goblet cell differentiation | 8.04e-06 | 2 | 59 | 2 | GO:1901250 | |
| GeneOntologyBiologicalProcess | glycolytic process | 1.57e-05 | 110 | 59 | 5 | GO:0006096 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 1.86e-05 | 114 | 59 | 5 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 2.11e-05 | 117 | 59 | 5 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 2.11e-05 | 117 | 59 | 5 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 2.29e-05 | 119 | 59 | 5 | GO:0019364 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 2.31e-05 | 416 | 59 | 8 | GO:0030522 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 2.39e-05 | 120 | 59 | 5 | GO:0046031 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 2.40e-05 | 202 | 59 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of lung goblet cell differentiation | 2.41e-05 | 3 | 59 | 2 | GO:1901249 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 2.41e-05 | 3 | 59 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 2.48e-05 | 121 | 59 | 5 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 2.69e-05 | 123 | 59 | 5 | GO:0072526 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 2.69e-05 | 123 | 59 | 5 | GO:0051153 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 2.80e-05 | 124 | 59 | 5 | GO:0009134 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | TRERF1 NCOA2 SETD2 KMT2D YAP1 FOXP1 RORC CREB1 MN1 CREBBP EP300 STAT3 | 3.40e-05 | 1048 | 59 | 12 | GO:0014070 |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 3.78e-05 | 132 | 59 | 5 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 3.78e-05 | 132 | 59 | 5 | GO:0009179 | |
| GeneOntologyBiologicalProcess | behavior | NCOA2 CACNA1E HDAC4 OXR1 FOXP2 GIGYF2 FOXP1 CREB1 CREBBP EP300 STAT3 | 3.84e-05 | 891 | 59 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 4.35e-05 | 136 | 59 | 5 | GO:0030518 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 4.70e-05 | 598 | 59 | 9 | GO:0080135 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 4.81e-05 | 4 | 59 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 5.14e-05 | 605 | 59 | 9 | GO:0071407 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 5.35e-05 | 142 | 59 | 5 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 5.53e-05 | 143 | 59 | 5 | GO:0009185 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 6.11e-05 | 146 | 59 | 5 | GO:2000779 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 6.73e-05 | 149 | 59 | 5 | GO:0009132 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.87e-05 | 244 | 59 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 6.94e-05 | 150 | 59 | 5 | GO:0000018 | |
| GeneOntologyBiologicalProcess | spinal cord oligodendrocyte cell differentiation | 8.00e-05 | 5 | 59 | 2 | GO:0021529 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 8.11e-05 | 155 | 59 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 8.12e-05 | 80 | 59 | 4 | GO:0045911 | |
| GeneOntologyBiologicalProcess | response to ketone | 8.58e-05 | 254 | 59 | 6 | GO:1901654 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | 9.15e-05 | 257 | 59 | 6 | GO:0046034 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.13e-04 | 87 | 59 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | lung development | 1.17e-04 | 269 | 59 | 6 | GO:0030324 | |
| GeneOntologyBiologicalProcess | regulation of fat cell differentiation | 1.19e-04 | 168 | 59 | 5 | GO:0045598 | |
| GeneOntologyBiologicalProcess | lung goblet cell differentiation | 1.20e-04 | 6 | 59 | 2 | GO:0060480 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 1.22e-04 | 169 | 59 | 5 | GO:0009154 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 1.27e-04 | 273 | 59 | 6 | GO:0030323 | |
| GeneOntologyBiologicalProcess | tube development | SETD2 FOXP4 FOXP2 YAP1 ARID2 ANGPT4 AMOTL1 FOXP1 WWTR1 CREB1 PGK1 EP300 STAT3 | 1.33e-04 | 1402 | 59 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | T-helper cell differentiation | 1.40e-04 | 92 | 59 | 4 | GO:0042093 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 1.44e-04 | 540 | 59 | 8 | GO:1903706 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation involved in immune response | 1.52e-04 | 94 | 59 | 4 | GO:0002294 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 1.55e-04 | 283 | 59 | 6 | GO:0009205 | |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 1.55e-04 | 178 | 59 | 5 | GO:0009261 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation involved in immune response | 1.58e-04 | 95 | 59 | 4 | GO:0002293 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.58e-04 | 95 | 59 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 1.67e-04 | 7 | 59 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule epithelial cell differentiation | 1.67e-04 | 7 | 59 | 2 | GO:0072257 | |
| GeneOntologyBiologicalProcess | regulation of metanephric nephron tubule epithelial cell differentiation | 1.67e-04 | 7 | 59 | 2 | GO:0072307 | |
| GeneOntologyBiologicalProcess | lobar bronchus epithelium development | 1.67e-04 | 7 | 59 | 2 | GO:0060481 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrogen peroxide-mediated programmed cell death | 1.67e-04 | 7 | 59 | 2 | GO:1901300 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 1.72e-04 | 182 | 59 | 5 | GO:0006195 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 1.77e-04 | 290 | 59 | 6 | GO:0009199 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation involved in immune response | 1.78e-04 | 98 | 59 | 4 | GO:0002287 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.80e-04 | 558 | 59 | 8 | GO:0060537 | |
| GeneOntologyBiologicalProcess | fat cell differentiation | 1.80e-04 | 291 | 59 | 6 | GO:0045444 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 1.80e-04 | 291 | 59 | 6 | GO:0009144 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 2.00e-04 | 188 | 59 | 5 | GO:0072523 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 2.00e-04 | 188 | 59 | 5 | GO:0000724 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 2.15e-04 | 429 | 59 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | T cell differentiation involved in immune response | 2.16e-04 | 103 | 59 | 4 | GO:0002292 | |
| GeneOntologyBiologicalProcess | lobar bronchus development | 2.23e-04 | 8 | 59 | 2 | GO:0060482 | |
| GeneOntologyBiologicalProcess | recombinational repair | 2.32e-04 | 194 | 59 | 5 | GO:0000725 | |
| GeneOntologyBiologicalProcess | respiratory system development | 2.32e-04 | 305 | 59 | 6 | GO:0060541 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 2.40e-04 | 307 | 59 | 6 | GO:0009141 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 2.43e-04 | 196 | 59 | 5 | GO:0016052 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 2.56e-04 | 748 | 59 | 9 | GO:0071396 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 2.61e-04 | 199 | 59 | 5 | GO:0051147 | |
| GeneOntologyBiologicalProcess | striated muscle cell proliferation | 2.78e-04 | 110 | 59 | 4 | GO:0014855 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 2.79e-04 | 202 | 59 | 5 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 2.79e-04 | 202 | 59 | 5 | GO:0019362 | |
| GeneOntologyBiologicalProcess | response to progesterone | 2.90e-04 | 45 | 59 | 3 | GO:0032570 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 3.19e-04 | 114 | 59 | 4 | GO:1900182 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 3.20e-04 | 208 | 59 | 5 | GO:0009166 | |
| GeneOntologyBiologicalProcess | T-helper 17 cell differentiation | 3.30e-04 | 47 | 59 | 3 | GO:0072539 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 3.34e-04 | 210 | 59 | 5 | GO:0072524 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 3.34e-04 | 210 | 59 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 3.37e-04 | 327 | 59 | 6 | GO:0048738 | |
| GeneOntologyBiologicalProcess | DNA damage response | 3.56e-04 | 959 | 59 | 10 | GO:0006974 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation | 3.75e-04 | 119 | 59 | 4 | GO:0043367 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 3.79e-04 | 789 | 59 | 9 | GO:0002521 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 3.80e-04 | 216 | 59 | 5 | GO:1901292 | |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle cell differentiation | 4.20e-04 | 51 | 59 | 3 | GO:0051154 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 4.45e-04 | 52 | 59 | 3 | GO:0042789 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 4.76e-04 | 349 | 59 | 6 | GO:0014706 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 4.91e-04 | 999 | 59 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 5.16e-04 | 231 | 59 | 5 | GO:0006109 | |
| GeneOntologyBiologicalProcess | hippo signaling | 5.25e-04 | 55 | 59 | 3 | GO:0035329 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 5.47e-04 | 234 | 59 | 5 | GO:0006282 | |
| GeneOntologyCellularComponent | transcription regulator complex | TRERF1 SOX6 NCOA2 HDAC4 YAP1 ARID2 WWTR1 CREB1 CREBBP EP300 STAT3 | 7.46e-07 | 596 | 59 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | SOX6 NCOA2 EPC2 FOXP4 HDAC4 FOXP2 ARID2 EPC1 MITF FOXP1 RORC CREB1 CREBBP SOX13 EP300 STAT3 | 2.19e-06 | 1480 | 59 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear body | NCOA2 HDAC4 SF3A1 EPC1 SGO2 RORC WWTR1 RO60 MAML2 CREBBP MAML3 | 3.84e-05 | 903 | 59 | 11 | GO:0016604 |
| GeneOntologyCellularComponent | piccolo histone acetyltransferase complex | 4.68e-05 | 4 | 59 | 2 | GO:0032777 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 NCOA2 KMT2D HDAC4 YAP1 ASXL3 ARID2 SF3A1 AMOTL1 MED12L CREB1 CREBBP STAT3 | 9.71e-05 | 1377 | 59 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.44e-04 | 94 | 59 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.13e-04 | 104 | 59 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.55e-04 | 109 | 59 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.01e-03 | 272 | 59 | 5 | GO:0090575 | |
| HumanPheno | Prominent fingertip pads | 4.10e-09 | 46 | 29 | 7 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 5.59e-09 | 48 | 29 | 7 | HP:0011298 | |
| HumanPheno | Prominent forehead | 8.60e-06 | 261 | 29 | 9 | HP:0011220 | |
| HumanPheno | Narrow palate | 1.11e-05 | 202 | 29 | 8 | HP:0000189 | |
| HumanPheno | Low hanging columella | 1.30e-05 | 56 | 29 | 5 | HP:0009765 | |
| HumanPheno | Abnormal columella morphology | 1.36e-05 | 97 | 29 | 6 | HP:0009929 | |
| HumanPheno | Pilomatrixoma | 1.36e-05 | 9 | 29 | 3 | HP:0030434 | |
| HumanPheno | Short columella | 1.82e-05 | 29 | 29 | 4 | HP:0002000 | |
| HumanPheno | High, narrow palate | 1.95e-05 | 156 | 29 | 7 | HP:0002705 | |
| HumanPheno | Abnormal size of the palpebral fissures | 2.52e-05 | 298 | 29 | 9 | HP:0200007 | |
| HumanPheno | Abnormal eyebrow morphology | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 ARID2 MITF MED12L MN1 CREBBP EP300 | 3.01e-05 | 674 | 29 | 13 | HP:0000534 |
| HumanPheno | Frontal upsweep of hair | 3.09e-05 | 33 | 29 | 4 | HP:0002236 | |
| HumanPheno | Plantar crease between first and second toes | 3.13e-05 | 2 | 29 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 3.13e-05 | 2 | 29 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 3.13e-05 | 2 | 29 | 2 | HP:0001042 | |
| HumanPheno | Abnormal nasal septum morphology | 3.61e-05 | 115 | 29 | 6 | HP:0000419 | |
| HumanPheno | Nasolacrimal duct obstruction | 4.40e-05 | 36 | 29 | 4 | HP:0000579 | |
| HumanPheno | Downslanted palpebral fissures | SETD2 KMT2D LZTR1 ASXL3 ARID2 MED12L FOXP1 MN1 CREBBP EP300 DYNC1H1 | 4.61e-05 | 497 | 29 | 11 | HP:0000494 |
| HumanPheno | Abnormal hair whorl | 8.17e-05 | 42 | 29 | 4 | HP:0010721 | |
| HumanPheno | Diagnostic behavioral phenotype | SOX6 SETD2 KMT2D HDAC4 FOXP2 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 CREBBP EP300 | 9.09e-05 | 747 | 29 | 13 | HP:0025783 |
| HumanPheno | Laryngeal cartilage malformation | 9.36e-05 | 3 | 29 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 9.36e-05 | 3 | 29 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 9.36e-05 | 3 | 29 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 9.36e-05 | 3 | 29 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 9.36e-05 | 3 | 29 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 9.36e-05 | 3 | 29 | 2 | HP:0005895 | |
| HumanPheno | Meningioma | 9.83e-05 | 44 | 29 | 4 | HP:0002858 | |
| HumanPheno | Delayed speech and language development | CACNA1E SETD2 KMT2D HDAC4 OXR1 FOXP2 ASXL3 ARID2 MED12L GRIA3 FOXP1 MN1 CREBBP PGK1 EP300 DYNC1H1 | 9.98e-05 | 1123 | 29 | 16 | HP:0000750 |
| HumanPheno | Regional abnormality of skin | KMT2D LZTR1 DST HDAC4 FOXP2 ASXL3 MED12L FOXP1 CREBBP EP300 STAT3 | 1.01e-04 | 541 | 29 | 11 | HP:0011356 |
| HumanPheno | Abnormal fingertip morphology | 1.06e-04 | 203 | 29 | 7 | HP:0001211 | |
| HumanPheno | Premature thelarche | 1.07e-04 | 17 | 29 | 3 | HP:0010314 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 1.11e-04 | 87 | 29 | 5 | HP:0000614 | |
| HumanPheno | Abnormality of calvarial morphology | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 ARID2 MITF MED12L GRIA3 MN1 CREBBP EP300 DYNC1H1 STAT3 | 1.13e-04 | 1134 | 29 | 16 | HP:0002648 |
| HumanPheno | Abnormality of the palpebral fissures | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 ARID2 MED12L FOXP1 MN1 CREBBP EP300 DYNC1H1 | 1.13e-04 | 880 | 29 | 14 | HP:0008050 |
| HumanPheno | Highly arched eyebrow | 1.17e-04 | 206 | 29 | 7 | HP:0002553 | |
| HumanPheno | Skin appendage neoplasm | 1.28e-04 | 18 | 29 | 3 | HP:0012842 | |
| HumanPheno | Chiari type I malformation | 1.39e-04 | 48 | 29 | 4 | HP:0007099 | |
| HumanPheno | Hirsutism | 1.57e-04 | 216 | 29 | 7 | HP:0001007 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.63e-04 | 50 | 29 | 4 | HP:0011481 | |
| HumanPheno | Abnormality of mouth shape | 1.65e-04 | 294 | 29 | 8 | HP:0011338 | |
| HumanPheno | Autistic behavior | SOX6 SETD2 KMT2D HDAC4 FOXP2 ASXL3 ARID2 MED12L GRIA3 FOXP1 CREBBP EP300 | 1.67e-04 | 678 | 29 | 12 | HP:0000729 |
| HumanPheno | Language impairment | CACNA1E SETD2 KMT2D HDAC4 OXR1 FOXP2 ASXL3 ARID2 MED12L GRIA3 FOXP1 MN1 CREBBP PGK1 EP300 DYNC1H1 | 1.83e-04 | 1178 | 29 | 16 | HP:0002463 |
| HumanPheno | Thick eyebrow | 1.85e-04 | 154 | 29 | 6 | HP:0000574 | |
| HumanPheno | Trichiasis | 1.86e-04 | 4 | 29 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.86e-04 | 4 | 29 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.86e-04 | 4 | 29 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.86e-04 | 4 | 29 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.86e-04 | 4 | 29 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.86e-04 | 4 | 29 | 2 | HP:0031207 | |
| HumanPheno | Abnormality of tear glands or tear production | 1.98e-04 | 156 | 29 | 6 | HP:0000521 | |
| HumanPheno | Corneal scarring | 2.06e-04 | 21 | 29 | 3 | HP:0000559 | |
| HumanPheno | Abnormal midface morphology | SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 MITF GRIA3 FOXP1 MN1 CREBBP EP300 | 2.40e-04 | 704 | 29 | 12 | HP:0000309 |
| HumanPheno | Expressive language delay | 2.54e-04 | 56 | 29 | 4 | HP:0002474 | |
| HumanPheno | Language delay | 2.54e-04 | 56 | 29 | 4 | HP:0002336 | |
| HumanPheno | Underdeveloped nasal alae | 2.59e-04 | 104 | 29 | 5 | HP:0000430 | |
| HumanPheno | Hypertelorism | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 MED12L FOXP1 MN1 CREBBP EP300 STAT3 | 2.74e-04 | 830 | 29 | 13 | HP:0000316 |
| HumanPheno | Papillary cystadenoma of the epididymis | 3.10e-04 | 5 | 29 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 3.10e-04 | 5 | 29 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 3.10e-04 | 5 | 29 | 2 | HP:0030421 | |
| HumanPheno | Congenital abnormal hair pattern | 3.45e-04 | 327 | 29 | 8 | HP:0011361 | |
| HumanPheno | Aggressive behavior | SETD2 HDAC4 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 CREBBP EP300 | 3.52e-04 | 516 | 29 | 10 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | SETD2 HDAC4 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 CREBBP EP300 | 3.52e-04 | 516 | 29 | 10 | HP:0006919 |
| HumanPheno | Abnormality of globe location or size | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 YAP1 ASXL3 MITF MED12L GRIA3 FOXP1 MN1 CREBBP EP300 STAT3 | 3.67e-04 | 1246 | 29 | 16 | HP:0000489 |
| HumanPheno | Hypoplastic facial bones | 3.75e-04 | 331 | 29 | 8 | HP:0002692 | |
| HumanPheno | Slanting of the palpebral fissure | SETD2 KMT2D LZTR1 HDAC4 ASXL3 ARID2 MED12L FOXP1 MN1 CREBBP EP300 DYNC1H1 | 3.82e-04 | 739 | 29 | 12 | HP:0200006 |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 3.82e-04 | 332 | 29 | 8 | HP:0034261 | |
| HumanPheno | Abnormal semicircular canal morphology | 3.95e-04 | 26 | 29 | 3 | HP:0011380 | |
| HumanPheno | Abnormal calvaria morphology | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 ARID2 MITF MED12L GRIA3 MN1 CREBBP EP300 DYNC1H1 STAT3 | 3.96e-04 | 1254 | 29 | 16 | HP:0002683 |
| HumanPheno | Abnormality of globe location | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 MITF MED12L GRIA3 FOXP1 MN1 CREBBP EP300 STAT3 | 4.18e-04 | 1122 | 29 | 15 | HP:0100886 |
| HumanPheno | Abnormal morphology of the nasal alae | SETD2 KMT2D LZTR1 HDAC4 ASXL3 ARID2 MITF MED12L FOXP1 MN1 CREBBP | 4.53e-04 | 639 | 29 | 11 | HP:0000429 |
| HumanPheno | Eversion of lateral third of lower eyelids | 4.63e-04 | 6 | 29 | 2 | HP:0007655 | |
| HumanPheno | Large foramen magnum | 4.63e-04 | 6 | 29 | 2 | HP:0002700 | |
| HumanPheno | Short palpebral fissure | 5.44e-04 | 122 | 29 | 5 | HP:0012745 | |
| HumanPheno | Deeply set eye | 5.66e-04 | 266 | 29 | 7 | HP:0000490 | |
| HumanPheno | Open mouth | 5.86e-04 | 124 | 29 | 5 | HP:0000194 | |
| HumanPheno | Deviated nasal septum | 6.46e-04 | 7 | 29 | 2 | HP:0004411 | |
| HumanPheno | Reduced impulse control | SOX6 SETD2 HDAC4 FOXP2 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 MN1 CREBBP EP300 STAT3 | 6.50e-04 | 1032 | 29 | 14 | HP:5200045 |
| HumanPheno | Anteverted nares | 6.73e-04 | 559 | 29 | 10 | HP:0000463 | |
| HumanPheno | Upturned nose | 6.73e-04 | 559 | 29 | 10 | HP:0000427 | |
| HumanPheno | Abnormal hair pattern | SOX6 SETD2 KMT2D LZTR1 HDAC4 ASXL3 ARID2 MITF FOXP1 CREBBP EP300 | 7.40e-04 | 676 | 29 | 11 | HP:0010720 |
| HumanPheno | Abnormal external nose morphology | SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 ARID2 MITF MED12L FOXP1 MN1 CREBBP EP300 | 7.42e-04 | 916 | 29 | 13 | HP:0010938 |
| HumanPheno | High palate | SOX6 KMT2D LZTR1 DST FOXP2 ASXL3 ARID2 MED12L MN1 CREBBP EP300 STAT3 | 7.51e-04 | 794 | 29 | 12 | HP:0000218 |
| HumanPheno | Syringomyelia | 8.07e-04 | 33 | 29 | 3 | HP:0003396 | |
| HumanPheno | Abnormal morphology of the vestibule of the inner ear | 8.07e-04 | 33 | 29 | 3 | HP:0011376 | |
| HumanPheno | Clinodactyly | 8.31e-04 | 574 | 29 | 10 | HP:0030084 | |
| HumanPheno | Abnormal nostril morphology | 8.43e-04 | 575 | 29 | 10 | HP:0005288 | |
| HumanPheno | Disinhibition | SOX6 SETD2 HDAC4 FOXP2 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 CREBBP EP300 | 8.73e-04 | 807 | 29 | 12 | HP:0000734 |
| HumanPheno | Inappropriate behavior | SOX6 SETD2 HDAC4 FOXP2 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 CREBBP EP300 | 8.73e-04 | 807 | 29 | 12 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | SOX6 SETD2 HDAC4 FOXP2 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 CREBBP EP300 | 8.73e-04 | 807 | 29 | 12 | HP:5200123 |
| HumanPheno | Social disinhibition | SOX6 SETD2 HDAC4 FOXP2 ASXL3 ARID2 MED12L GIGYF2 GRIA3 FOXP1 CREBBP EP300 | 8.73e-04 | 807 | 29 | 12 | HP:5200029 |
| HumanPheno | Aspiration | 8.82e-04 | 34 | 29 | 3 | HP:0002835 | |
| HumanPheno | Abnormality of the forehead | SOX6 SETD2 KMT2D LZTR1 HDAC4 ASXL3 ARID2 MITF MED12L FOXP1 MN1 CREBBP EP300 DYNC1H1 STAT3 | 9.67e-04 | 1208 | 29 | 15 | HP:0000290 |
| HumanPheno | Self-injurious behavior | 9.79e-04 | 210 | 29 | 6 | HP:0100716 | |
| HumanPheno | Abnormal helix morphology | 1.03e-03 | 212 | 29 | 6 | HP:0011039 | |
| HumanPheno | Hydrocele testis | 1.04e-03 | 36 | 29 | 3 | HP:0000034 | |
| HumanPheno | Cerebellar malformation | 1.08e-03 | 487 | 29 | 9 | HP:0002438 | |
| HumanPheno | Abnormal facial shape | SOX6 SETD2 KMT2D LZTR1 HDAC4 FOXP2 ASXL3 ARID2 MED12L GRIA3 FOXP1 MN1 CREBBP EP300 STAT3 | 1.09e-03 | 1221 | 29 | 15 | HP:0001999 |
| HumanPheno | Overfolded helix | 1.09e-03 | 82 | 29 | 4 | HP:0000396 | |
| HumanPheno | Cervical cord compression | 1.10e-03 | 9 | 29 | 2 | HP:0002341 | |
| HumanPheno | Nasogastric tube feeding in infancy | 1.13e-03 | 37 | 29 | 3 | HP:0011470 | |
| MousePheno | postnatal lethality | SOX6 DST HDAC4 TIA1 FOXP2 AMOTL1 EPC1 MITF GIGYF2 WWTR1 CREB1 CREBBP EP300 STAT3 | 2.22e-05 | 1084 | 51 | 14 | MP:0002082 |
| MousePheno | thin myocardium compact layer | 2.29e-05 | 46 | 51 | 4 | MP:0004057 | |
| MousePheno | thin ventricle myocardium compact layer | 4.99e-05 | 20 | 51 | 3 | MP:0010556 | |
| MousePheno | hypoactivity | NCOA2 EPC2 FBXO25 DST CHERP HDAC4 FOXP2 GIGYF2 WWTR1 CREB1 MN1 CREBBP DYNC1H1 | 5.55e-05 | 1023 | 51 | 13 | MP:0031392 |
| MousePheno | abnormal myocardium compact layer morphology | 1.02e-04 | 67 | 51 | 4 | MP:0004056 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | SOX6 TIA1 FOXP2 SGTA AMOTL1 GIGYF2 FOXP1 WWTR1 CREB1 MN1 CREBBP EP300 STAT3 | 1.45e-04 | 1124 | 51 | 13 | MP:0011112 |
| MousePheno | decreased locomotor activity | NCOA2 EPC2 FBXO25 DST CHERP HDAC4 FOXP2 GIGYF2 WWTR1 CREBBP DYNC1H1 | 1.60e-04 | 829 | 51 | 11 | MP:0001402 |
| MousePheno | pale lung | 1.94e-04 | 6 | 51 | 2 | MP:0010887 | |
| MousePheno | myocardium hypoplasia | 2.68e-04 | 86 | 51 | 4 | MP:0010500 | |
| Domain | FOXP-CC | 1.08e-07 | 4 | 57 | 3 | PF16159 | |
| Domain | FOXP-CC | 1.08e-07 | 4 | 57 | 3 | IPR032354 | |
| Domain | Nuc_rcpt_coact | 5.36e-07 | 6 | 57 | 3 | IPR009110 | |
| Domain | Nuc_rcpt_coact_CREBbp | 9.15e-06 | 2 | 57 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 9.15e-06 | 2 | 57 | 2 | PF08214 | |
| Domain | KIX | 9.15e-06 | 2 | 57 | 2 | PS50952 | |
| Domain | PGLYCERATE_KINASE | 9.15e-06 | 2 | 57 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 9.15e-06 | 2 | 57 | 2 | IPR015824 | |
| Domain | ZnF_TAZ | 9.15e-06 | 2 | 57 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 9.15e-06 | 2 | 57 | 2 | IPR031162 | |
| Domain | Phosphoglycerate_kinase_CS | 9.15e-06 | 2 | 57 | 2 | IPR015911 | |
| Domain | DUF902 | 9.15e-06 | 2 | 57 | 2 | PF06001 | |
| Domain | Phosphoglycerate_kinase_C | 9.15e-06 | 2 | 57 | 2 | IPR015901 | |
| Domain | - | 9.15e-06 | 2 | 57 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 9.15e-06 | 2 | 57 | 2 | IPR010303 | |
| Domain | - | 9.15e-06 | 2 | 57 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 9.15e-06 | 2 | 57 | 2 | PF09030 | |
| Domain | Enhancer_polycomb | 9.15e-06 | 2 | 57 | 2 | IPR024943 | |
| Domain | - | 9.15e-06 | 2 | 57 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 9.15e-06 | 2 | 57 | 2 | PF02135 | |
| Domain | ZF_TAZ | 9.15e-06 | 2 | 57 | 2 | PS50134 | |
| Domain | - | 9.15e-06 | 2 | 57 | 2 | 3.40.50.1270 | |
| Domain | - | 9.15e-06 | 2 | 57 | 2 | 3.40.50.1260 | |
| Domain | Enhancer_polycomb_C | 9.15e-06 | 2 | 57 | 2 | IPR009607 | |
| Domain | PGK | 9.15e-06 | 2 | 57 | 2 | PF00162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 9.15e-06 | 2 | 57 | 2 | IPR013178 | |
| Domain | KAT11 | 9.15e-06 | 2 | 57 | 2 | SM01250 | |
| Domain | Znf_TAZ | 9.15e-06 | 2 | 57 | 2 | IPR000197 | |
| Domain | KIX_dom | 9.15e-06 | 2 | 57 | 2 | IPR003101 | |
| Domain | KIX | 9.15e-06 | 2 | 57 | 2 | PF02172 | |
| Domain | E_Pc_C | 9.15e-06 | 2 | 57 | 2 | PF06752 | |
| Domain | CBP_P300_HAT | 9.15e-06 | 2 | 57 | 2 | PS51727 | |
| Domain | Phosphoglycerate_kinase | 2.74e-05 | 3 | 57 | 2 | IPR001576 | |
| Domain | Neuroggenic_mastermind-like_N | 2.74e-05 | 3 | 57 | 2 | IPR019082 | |
| Domain | MamL-1 | 2.74e-05 | 3 | 57 | 2 | PF09596 | |
| Domain | MamL-1 | 2.74e-05 | 3 | 57 | 2 | SM01275 | |
| Domain | Surp | 1.36e-04 | 6 | 57 | 2 | PF01805 | |
| Domain | SWAP | 1.36e-04 | 6 | 57 | 2 | SM00648 | |
| Domain | SURP | 1.36e-04 | 6 | 57 | 2 | PS50128 | |
| Domain | Surp | 1.36e-04 | 6 | 57 | 2 | IPR000061 | |
| Domain | EPL1 | 2.53e-04 | 8 | 57 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 2.53e-04 | 8 | 57 | 2 | IPR019542 | |
| Domain | TF_fork_head_CS_2 | 3.73e-04 | 46 | 57 | 3 | IPR030456 | |
| Domain | ubiquitin | 3.97e-04 | 47 | 57 | 3 | PF00240 | |
| Domain | TF_fork_head_CS_1 | 3.97e-04 | 47 | 57 | 3 | IPR018122 | |
| Domain | WW | 3.97e-04 | 47 | 57 | 3 | PF00397 | |
| Domain | WW | 4.23e-04 | 48 | 57 | 3 | SM00456 | |
| Domain | FH | 4.49e-04 | 49 | 57 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.49e-04 | 49 | 57 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.49e-04 | 49 | 57 | 3 | PS00658 | |
| Domain | Fork_head_dom | 4.49e-04 | 49 | 57 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 4.49e-04 | 49 | 57 | 3 | PS50039 | |
| Domain | Forkhead | 4.49e-04 | 49 | 57 | 3 | PF00250 | |
| Domain | WW_DOMAIN_2 | 5.06e-04 | 51 | 57 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 5.06e-04 | 51 | 57 | 3 | PS01159 | |
| Domain | WW_dom | 5.36e-04 | 52 | 57 | 3 | IPR001202 | |
| Domain | HMG_box | 5.67e-04 | 53 | 57 | 3 | PF00505 | |
| Domain | UBIQUITIN_2 | 5.99e-04 | 54 | 57 | 3 | PS50053 | |
| Domain | HMG | 5.99e-04 | 54 | 57 | 3 | SM00398 | |
| Domain | - | 6.32e-04 | 55 | 57 | 3 | 1.10.30.10 | |
| Domain | Ubiquitin_dom | 7.38e-04 | 58 | 57 | 3 | IPR000626 | |
| Domain | HMG_box_dom | 1.03e-03 | 65 | 57 | 3 | IPR009071 | |
| Domain | Post-SET_dom | 1.07e-03 | 16 | 57 | 2 | IPR003616 | |
| Domain | PostSET | 1.07e-03 | 16 | 57 | 2 | SM00508 | |
| Domain | POST_SET | 1.07e-03 | 16 | 57 | 2 | PS50868 | |
| Domain | ZZ | 1.36e-03 | 18 | 57 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.36e-03 | 18 | 57 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.36e-03 | 18 | 57 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.51e-03 | 19 | 57 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.51e-03 | 19 | 57 | 2 | SM00291 | |
| Domain | Bromodomain_CS | 2.84e-03 | 26 | 57 | 2 | IPR018359 | |
| Domain | UBA | 3.77e-03 | 30 | 57 | 2 | SM00165 | |
| Domain | - | 4.40e-03 | 218 | 57 | 4 | 1.10.10.10 | |
| Domain | UBA | 5.39e-03 | 36 | 57 | 2 | PF00627 | |
| Domain | BROMODOMAIN_1 | 5.69e-03 | 37 | 57 | 2 | PS00633 | |
| Domain | UBIQUITIN_1 | 5.69e-03 | 37 | 57 | 2 | PS00299 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 6.03e-10 | 96 | 45 | 8 | M27784 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.40e-08 | 12 | 45 | 4 | M27159 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 8.86e-08 | 14 | 45 | 4 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.60e-07 | 16 | 45 | 4 | M27121 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 2.91e-07 | 86 | 45 | 6 | M39375 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.08e-07 | 48 | 45 | 5 | M611 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.23e-07 | 20 | 45 | 4 | M27881 | |
| Pathway | BIOCARTA_MELANOCYTE_PATHWAY | 1.05e-06 | 7 | 45 | 3 | M22035 | |
| Pathway | BIOCARTA_MELANOCYTE_PATHWAY | 1.05e-06 | 7 | 45 | 3 | MM1555 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.07e-06 | 58 | 45 | 5 | M29616 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.09e-06 | 25 | 45 | 4 | M27880 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.75e-06 | 28 | 45 | 4 | M6177 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.89e-06 | 65 | 45 | 5 | M39682 | |
| Pathway | PID_HIF1_TFPATHWAY | 2.04e-06 | 66 | 45 | 5 | M255 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 3.46e-06 | 33 | 45 | 4 | M604 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.59e-06 | 10 | 45 | 3 | MM15535 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.61e-06 | 74 | 45 | 5 | M616 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 4.12e-06 | 76 | 45 | 5 | MM15520 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 4.93e-06 | 11 | 45 | 3 | MM1521 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.55e-06 | 12 | 45 | 3 | M7968 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 9.28e-06 | 42 | 45 | 4 | M17541 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.00e-05 | 91 | 45 | 5 | M39700 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.46e-05 | 47 | 45 | 4 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.59e-05 | 48 | 45 | 4 | M288 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.73e-05 | 49 | 45 | 4 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.73e-05 | 49 | 45 | 4 | M618 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.00e-05 | 17 | 45 | 3 | M48025 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.23e-05 | 272 | 45 | 7 | M29619 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.40e-05 | 18 | 45 | 3 | M26942 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.40e-05 | 18 | 45 | 3 | MM14775 | |
| Pathway | REACTOME_SIGNALING_BY_HIPPO | 3.34e-05 | 20 | 45 | 3 | MM14813 | |
| Pathway | REACTOME_SIGNALING_BY_HIPPO | 3.34e-05 | 20 | 45 | 3 | M591 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 4.14e-05 | 61 | 45 | 4 | M39540 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 4.27e-05 | 301 | 45 | 7 | MM15983 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.15e-05 | 23 | 45 | 3 | MM14954 | |
| Pathway | REACTOME_GASTRULATION | 5.41e-05 | 129 | 45 | 5 | M46433 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 5.65e-05 | 66 | 45 | 4 | M101 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 6.73e-05 | 69 | 45 | 4 | M46439 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 7.12e-05 | 70 | 45 | 4 | M938 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 7.51e-05 | 26 | 45 | 3 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 7.51e-05 | 26 | 45 | 3 | M32 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 9.90e-05 | 5 | 45 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 9.90e-05 | 5 | 45 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 9.90e-05 | 5 | 45 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 9.90e-05 | 5 | 45 | 2 | M27228 | |
| Pathway | WP_ESTROGEN_SIGNALING | 1.03e-04 | 77 | 45 | 4 | MM15934 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.16e-04 | 30 | 45 | 3 | M207 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.22e-04 | 246 | 45 | 6 | M10189 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 1.28e-04 | 31 | 45 | 3 | M27805 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.32e-04 | 82 | 45 | 4 | MM15922 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.32e-04 | 82 | 45 | 4 | M2 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.32e-04 | 82 | 45 | 4 | M594 | |
| Pathway | PID_REG_GR_PATHWAY | 1.32e-04 | 82 | 45 | 4 | M115 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.41e-04 | 32 | 45 | 3 | M39521 | |
| Pathway | WP_PRION_DISEASE_PATHWAY | 1.41e-04 | 32 | 45 | 3 | M39636 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.48e-04 | 6 | 45 | 2 | M22062 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 1.48e-04 | 6 | 45 | 2 | MM15545 | |
| Pathway | WP_CAMKK2_PATHWAY | 1.55e-04 | 33 | 45 | 3 | M40047 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.70e-04 | 34 | 45 | 3 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 1.70e-04 | 34 | 45 | 3 | M44 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.07e-04 | 7 | 45 | 2 | MM1573 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.56e-04 | 39 | 45 | 3 | MM14604 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.76e-04 | 8 | 45 | 2 | M22058 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 2.76e-04 | 8 | 45 | 2 | MM14816 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 2.76e-04 | 8 | 45 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 2.76e-04 | 8 | 45 | 2 | M48024 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 2.76e-04 | 8 | 45 | 2 | M27823 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 2.76e-04 | 8 | 45 | 2 | M46443 | |
| Pathway | PID_IFNG_PATHWAY | 2.77e-04 | 40 | 45 | 3 | M161 | |
| Pathway | KEGG_MELANOGENESIS | 2.95e-04 | 101 | 45 | 4 | M7761 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.20e-04 | 42 | 45 | 3 | M27272 | |
| Pathway | REACTOME_SUMOYLATION | 3.25e-04 | 189 | 45 | 5 | M27214 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 3.54e-04 | 9 | 45 | 2 | M47451 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.67e-04 | 44 | 45 | 3 | M27295 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA2 KMT2D YAP1 MITF FOXP1 KIF4B WWTR1 MAML2 CREB1 CREBBP MAML3 EP300 STAT3 | 3.78e-04 | 1432 | 45 | 13 | M509 |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 3.95e-04 | 431 | 45 | 7 | M39729 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 4.41e-04 | 10 | 45 | 2 | M27824 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 4.41e-04 | 10 | 45 | 2 | M27945 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 5.38e-04 | 11 | 45 | 2 | M48021 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 5.38e-04 | 11 | 45 | 2 | M42523 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 5.38e-04 | 11 | 45 | 2 | M26924 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.51e-04 | 119 | 45 | 4 | M607 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY | 5.69e-04 | 51 | 45 | 3 | M48267 | |
| Pathway | PID_KIT_PATHWAY | 6.02e-04 | 52 | 45 | 3 | M231 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 6.08e-04 | 768 | 45 | 9 | MM14851 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 6.14e-04 | 464 | 45 | 7 | M27547 | |
| Pathway | PID_AR_TF_PATHWAY | 6.37e-04 | 53 | 45 | 3 | M151 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 6.37e-04 | 53 | 45 | 3 | MM15880 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 6.44e-04 | 12 | 45 | 2 | M27765 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 6.44e-04 | 12 | 45 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 6.44e-04 | 12 | 45 | 2 | M47533 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 7.10e-04 | 55 | 45 | 3 | M39351 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 7.10e-04 | 55 | 45 | 3 | M27145 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION | 7.60e-04 | 13 | 45 | 2 | M47595 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 7.60e-04 | 13 | 45 | 2 | M47534 | |
| Pathway | WP_ADIPOGENESIS | 7.90e-04 | 131 | 45 | 4 | M39505 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 8.42e-04 | 233 | 45 | 5 | M27099 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 8.72e-04 | 59 | 45 | 3 | M39350 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 8.72e-04 | 59 | 45 | 3 | M39886 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 9.09e-04 | 237 | 45 | 5 | M27786 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 NCOA2 EPC2 FOXP4 KMT2D HDAC4 FOXP2 ASXL3 ARID2 EPC1 MITF FOXP1 CREBBP SOX13 EP300 | 2.27e-17 | 351 | 59 | 15 | 38297188 |
| Pubmed | TRERF1 SOX6 NCOA2 FHAD1 EPC2 FOXP4 KMT2D UBAP2 DST FOXP2 YAP1 ARID2 EPC1 MITF GIGYF2 FOXP1 CLPX CREB1 CREBBP SOX13 EP300 DYNC1H1 STAT3 | 3.82e-17 | 1429 | 59 | 23 | 35140242 | |
| Pubmed | NCOA2 SETD2 KMT2D UBAP2 YAP1 ARID2 AMOTL1 GIGYF2 WWTR1 CREBBP EP300 DYNC1H1 STAT3 | 6.85e-12 | 549 | 59 | 13 | 38280479 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 EPC2 FOXP4 KMT2D FOXP2 SF3A1 EPC1 FOXP1 WWTR1 BTAF1 CREB1 CREBBP EP300 DYNC1H1 STAT3 | 9.67e-12 | 857 | 59 | 15 | 25609649 |
| Pubmed | 2.81e-11 | 268 | 59 | 10 | 33640491 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 EPC2 FOXP4 KMT2D ARID2 EPC1 FOXP1 RO60 CLPX CREBBP EP300 | 6.57e-11 | 398 | 59 | 11 | 35016035 |
| Pubmed | Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. | 1.12e-10 | 6 | 59 | 4 | 15961999 | |
| Pubmed | 2.60e-10 | 7 | 59 | 4 | 16332960 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SOX6 NCOA2 LZTR1 HDAC4 MITF FOXP1 RORC WWTR1 CREB1 CREBBP MAML3 EP300 STAT3 | 2.12e-09 | 877 | 59 | 13 | 20211142 |
| Pubmed | TRERF1 NCOA2 EPC2 KMT2D HDAC4 ARID2 SF3A1 FOXP1 CREB1 CREBBP PGK1 EP300 DYNC1H1 RAD23A | 3.37e-09 | 1103 | 59 | 14 | 34189442 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 18070920 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 14516685 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 15649887 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 4.64e-09 | 3 | 59 | 3 | 19907493 | |
| Pubmed | Transcriptional co-activator p300 maintains basal hepatic gluconeogenesis. | 4.64e-09 | 3 | 59 | 3 | 22815486 | |
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 4.64e-09 | 3 | 59 | 3 | 25027557 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 7870179 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 28507505 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 11349124 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 11313407 | ||
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 14701752 | ||
| Pubmed | Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. | 1.85e-08 | 4 | 59 | 3 | 17707401 | |
| Pubmed | Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. | 1.85e-08 | 4 | 59 | 3 | 17525731 | |
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 11196199 | ||
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 24338025 | ||
| Pubmed | Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53. | 1.85e-08 | 4 | 59 | 3 | 16611888 | |
| Pubmed | Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB. | 1.85e-08 | 4 | 59 | 3 | 12437352 | |
| Pubmed | Identification and characterization of T reg-like cells in zebrafish. | 1.85e-08 | 4 | 59 | 3 | 29066577 | |
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 28398509 | ||
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 27527859 | ||
| Pubmed | MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. | 1.85e-08 | 4 | 59 | 3 | 32482852 | |
| Pubmed | 4.62e-08 | 57 | 59 | 5 | 18022353 | ||
| Pubmed | Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. | 4.63e-08 | 5 | 59 | 3 | 17476304 | |
| Pubmed | Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. | 4.63e-08 | 5 | 59 | 3 | 10464260 | |
| Pubmed | Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. | 4.63e-08 | 5 | 59 | 3 | 21205866 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 17467007 | ||
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 27215660 | ||
| Pubmed | Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. | 4.63e-08 | 5 | 59 | 3 | 11239394 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 11923478 | ||
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 25707758 | ||
| Pubmed | TRERF1 NCOA2 CACNA1E UBAP2 DST HDAC4 FOXP2 GIGYF2 GRIA3 KIF4B PGK1 DYNC1H1 | 6.42e-08 | 963 | 59 | 12 | 28671696 | |
| Pubmed | 6.45e-08 | 23 | 59 | 4 | 9225980 | ||
| Pubmed | 9.24e-08 | 6 | 59 | 3 | 17619227 | ||
| Pubmed | 9.24e-08 | 6 | 59 | 3 | 15731352 | ||
| Pubmed | 9.24e-08 | 6 | 59 | 3 | 28504697 | ||
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 9.24e-08 | 6 | 59 | 3 | 20930143 | |
| Pubmed | 9.24e-08 | 6 | 59 | 3 | 28591638 | ||
| Pubmed | Stat3 dimerization regulated by reversible acetylation of a single lysine residue. | 9.24e-08 | 6 | 59 | 3 | 15653507 | |
| Pubmed | 1.48e-07 | 28 | 59 | 4 | 29365100 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 1.48e-07 | 28 | 59 | 4 | 31600191 | |
| Pubmed | 1.62e-07 | 7 | 59 | 3 | 37166352 | ||
| Pubmed | 1.62e-07 | 7 | 59 | 3 | 20185820 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.62e-07 | 7 | 59 | 3 | 9590696 | |
| Pubmed | 1.62e-07 | 7 | 59 | 3 | 15735682 | ||
| Pubmed | Acetylation-dependent signal transduction for type I interferon receptor. | 2.58e-07 | 8 | 59 | 3 | 17923090 | |
| Pubmed | The transcription factor Sox5 modulates Sox10 function during melanocyte development. | 2.58e-07 | 8 | 59 | 3 | 18703590 | |
| Pubmed | 2.58e-07 | 8 | 59 | 3 | 10490106 | ||
| Pubmed | 2.84e-07 | 157 | 59 | 6 | 30186101 | ||
| Pubmed | 2.97e-07 | 709 | 59 | 10 | 22988430 | ||
| Pubmed | EPC2 SETD2 FOXP4 LZTR1 FOXP2 ARID2 RTL9 EPC1 FOXP1 CLPX CREBBP EP300 | 3.13e-07 | 1116 | 59 | 12 | 31753913 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRERF1 SOX6 FOXP4 KMT2D FOXP2 MITF FOXP1 RORC CREB1 SOX13 STAT3 | 3.23e-07 | 908 | 59 | 11 | 19274049 |
| Pubmed | 3.87e-07 | 9 | 59 | 3 | 16801560 | ||
| Pubmed | Pax3 and hippo signaling coordinate melanocyte gene expression in neural crest. | 3.87e-07 | 9 | 59 | 3 | 25466249 | |
| Pubmed | Forkhead Box Protein P1 Is Dispensable for Retina but Essential for Lens Development. | 5.52e-07 | 10 | 59 | 3 | 28384713 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 6.54e-07 | 430 | 59 | 8 | 35044719 | |
| Pubmed | Foxp1/2/4 regulate endochondral ossification as a suppresser complex. | 7.58e-07 | 11 | 59 | 3 | 25527076 | |
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 8.77e-07 | 43 | 59 | 4 | 34672947 | |
| Pubmed | A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. | 1.31e-06 | 13 | 59 | 3 | 32929274 | |
| Pubmed | 1.35e-06 | 645 | 59 | 9 | 25281560 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPC2 SETD2 KMT2D DST CHERP YAP1 SF3A1 EPC1 MITF WWTR1 CREB1 EP300 | 1.48e-06 | 1294 | 59 | 12 | 30804502 |
| Pubmed | 1.63e-06 | 486 | 59 | 8 | 20936779 | ||
| Pubmed | 1.67e-06 | 14 | 59 | 3 | 12482968 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.04e-06 | 220 | 59 | 6 | 35785414 | |
| Pubmed | 2.56e-06 | 16 | 59 | 3 | 22542185 | ||
| Pubmed | 2.56e-06 | 16 | 59 | 3 | 26021489 | ||
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 2.57e-06 | 56 | 59 | 4 | 29184203 | |
| Pubmed | 2.76e-06 | 57 | 59 | 4 | 38223760 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27881875 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29115373 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21766169 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 35763355 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23954413 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 2.83e-06 | 2 | 59 | 2 | 34845315 | |
| Pubmed | YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction. | 2.83e-06 | 2 | 59 | 2 | 36350617 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30031127 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34463254 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34186485 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19729597 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 38105758 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28951564 | ||
| Pubmed | Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin. | 2.83e-06 | 2 | 59 | 2 | 33798262 | |
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 2.83e-06 | 2 | 59 | 2 | 30104377 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28512636 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30717258 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30009847 | ||
| Pubmed | Targeted Disruption of YAP and TAZ Impairs the Maintenance of the Adrenal Cortex. | 2.83e-06 | 2 | 59 | 2 | 28938438 | |
| Pubmed | The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine. | 2.83e-06 | 2 | 59 | 2 | 26758663 | |
| Pubmed | A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer. | 2.83e-06 | 2 | 59 | 2 | 32816858 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 39287984 | ||
| Pubmed | Heat stress activates YAP/TAZ to induce the heat shock transcriptome. | 2.83e-06 | 2 | 59 | 2 | 33199845 | |
| Interaction | EGR2 interactions | TRERF1 NCOA2 FOXP4 KMT2D HDAC4 FOXP2 ARID2 EPC1 MITF FOXP1 CREBBP EP300 | 7.47e-14 | 171 | 59 | 12 | int:EGR2 |
| Interaction | HNF1B interactions | SOX6 NCOA2 KMT2D YAP1 ARID2 EPC1 FOXP1 CREB1 CREBBP SOX13 EP300 | 7.38e-12 | 190 | 59 | 11 | int:HNF1B |
| Interaction | FEV interactions | NCOA2 FOXP4 KMT2D FOXP2 YAP1 ARID2 FOXP1 CREB1 CREBBP SOX13 EP300 | 1.51e-11 | 203 | 59 | 11 | int:FEV |
| Interaction | GSC interactions | 1.61e-10 | 87 | 59 | 8 | int:GSC | |
| Interaction | CRX interactions | TRERF1 NCOA2 EPC2 FOXP4 KMT2D FOXP2 ARID2 EPC1 FOXP1 CREBBP EP300 | 1.68e-10 | 254 | 59 | 11 | int:CRX |
| Interaction | KLF5 interactions | 2.38e-10 | 195 | 59 | 10 | int:KLF5 | |
| Interaction | SP7 interactions | TRERF1 NCOA2 EPC2 FOXP4 KMT2D ARID2 EPC1 MITF FOXP1 CREBBP EP300 | 1.13e-09 | 304 | 59 | 11 | int:SP7 |
| Interaction | CREBBP interactions | TRERF1 NCOA2 KMT2D YAP1 MITF GRIA3 WWTR1 RO60 MAML2 CREB1 CREBBP EP300 STAT3 RAD23A | 1.40e-09 | 599 | 59 | 14 | int:CREBBP |
| Interaction | AR interactions | TRERF1 NCOA2 FOXP4 KMT2D CHERP HDAC4 YAP1 ARID2 EPC1 MED12L FOXP1 CREB1 CREBBP PGK1 EP300 DYNC1H1 STAT3 | 2.00e-09 | 992 | 59 | 17 | int:AR |
| Interaction | KLF8 interactions | NCOA2 FHAD1 EPC2 FOXP4 KMT2D ARID2 EPC1 FOXP1 CLPX CREBBP EP300 | 2.59e-09 | 329 | 59 | 11 | int:KLF8 |
| Interaction | SOX7 interactions | 4.09e-09 | 82 | 59 | 7 | int:SOX7 | |
| Interaction | EP300 interactions | TRERF1 NCOA2 KMT2D YAP1 SF3A1 EPC1 MITF RORC WWTR1 BTAF1 MAML2 EEA1 CLPX CREB1 MN1 CREBBP EP300 STAT3 RAD23A | 8.46e-09 | 1401 | 59 | 19 | int:EP300 |
| Interaction | KLF15 interactions | 1.10e-08 | 290 | 59 | 10 | int:KLF15 | |
| Interaction | WWTR1 interactions | NCOA2 SETD2 KMT2D UBAP2 YAP1 ARID2 AMOTL1 WWTR1 CREBBP EP300 STAT3 | 3.38e-08 | 422 | 59 | 11 | int:WWTR1 |
| Interaction | SOX13 interactions | 5.49e-08 | 35 | 59 | 5 | int:SOX13 | |
| Interaction | NFIA interactions | 7.30e-08 | 188 | 59 | 8 | int:NFIA | |
| Interaction | HNF4A interactions | 9.96e-08 | 275 | 59 | 9 | int:HNF4A | |
| Interaction | CTNNB1 interactions | SOX6 NCOA2 KMT2D DST HDAC4 TIA1 YAP1 AMOTL1 MITF FOXP1 CREB1 CREBBP PGK1 EP300 DYNC1H1 | 1.41e-07 | 1009 | 59 | 15 | int:CTNNB1 |
| Interaction | SRF interactions | 1.61e-07 | 139 | 59 | 7 | int:SRF | |
| Interaction | IRF4 interactions | 1.77e-07 | 85 | 59 | 6 | int:IRF4 | |
| Interaction | NCOA6 interactions | 2.15e-07 | 145 | 59 | 7 | int:NCOA6 | |
| Interaction | ERG interactions | 2.71e-07 | 223 | 59 | 8 | int:ERG | |
| Interaction | FOXI1 interactions | 2.85e-07 | 92 | 59 | 6 | int:FOXI1 | |
| Interaction | FOXC1 interactions | 3.20e-07 | 228 | 59 | 8 | int:FOXC1 | |
| Interaction | PIAS3 interactions | 3.45e-07 | 95 | 59 | 6 | int:PIAS3 | |
| Interaction | YAP1 interactions | TRERF1 SETD2 KMT2D UBAP2 YAP1 ARID2 SF3A1 AMOTL1 GIGYF2 WWTR1 CREB1 CREBBP PGK1 EP300 DYNC1H1 | 4.03e-07 | 1095 | 59 | 15 | int:YAP1 |
| Interaction | HIF1A interactions | 5.48e-07 | 441 | 59 | 10 | int:HIF1A | |
| Interaction | TEAD1 interactions | 8.00e-07 | 176 | 59 | 7 | int:TEAD1 | |
| Interaction | PAX8 interactions | 8.66e-07 | 111 | 59 | 6 | int:PAX8 | |
| Interaction | GAPVD1 interactions | 9.30e-07 | 180 | 59 | 7 | int:GAPVD1 | |
| Interaction | TBXT interactions | 1.12e-06 | 116 | 59 | 6 | int:TBXT | |
| Interaction | CTBP2 interactions | 1.20e-06 | 370 | 59 | 9 | int:CTBP2 | |
| Interaction | TLE3 interactions | 1.37e-06 | 376 | 59 | 9 | int:TLE3 | |
| Interaction | GCM1 interactions | 1.64e-06 | 68 | 59 | 5 | int:GCM1 | |
| Interaction | RUNX2 interactions | 1.82e-06 | 126 | 59 | 6 | int:RUNX2 | |
| Interaction | SRCAP interactions | 1.91e-06 | 127 | 59 | 6 | int:SRCAP | |
| Interaction | MAML1 interactions | 2.33e-06 | 73 | 59 | 5 | int:MAML1 | |
| Interaction | TRERF1 interactions | 2.54e-06 | 33 | 59 | 4 | int:TRERF1 | |
| Interaction | PRRG2 interactions | 2.82e-06 | 10 | 59 | 3 | int:PRRG2 | |
| Interaction | PPARG interactions | 2.99e-06 | 307 | 59 | 8 | int:PPARG | |
| Interaction | FOS interactions | 3.37e-06 | 312 | 59 | 8 | int:FOS | |
| Interaction | SOX15 interactions | 3.50e-06 | 141 | 59 | 6 | int:SOX15 | |
| Interaction | HOXB2 interactions | 3.64e-06 | 36 | 59 | 4 | int:HOXB2 | |
| Interaction | GAS5 interactions | 3.87e-06 | 11 | 59 | 3 | int:GAS5 | |
| Interaction | ZNF148 interactions | 3.96e-06 | 144 | 59 | 6 | int:ZNF148 | |
| Interaction | RPS6KA5 interactions | 3.96e-06 | 144 | 59 | 6 | int:RPS6KA5 | |
| Interaction | NCOA3 interactions | 3.98e-06 | 224 | 59 | 7 | int:NCOA3 | |
| Interaction | SMC2 interactions | 4.35e-06 | 323 | 59 | 8 | int:SMC2 | |
| Interaction | KLF3 interactions | 4.48e-06 | 228 | 59 | 7 | int:KLF3 | |
| Interaction | NFAT5 interactions | 4.54e-06 | 38 | 59 | 4 | int:NFAT5 | |
| Interaction | TBX2 interactions | 5.60e-06 | 40 | 59 | 4 | int:TBX2 | |
| Interaction | CDC5L interactions | FOXP4 DST CHERP HDAC4 FOXP2 SF3A1 MED12L FOXP1 WWTR1 BTAF1 EP300 DYNC1H1 | 5.60e-06 | 855 | 59 | 12 | int:CDC5L |
| Interaction | RUVBL1 interactions | 5.90e-06 | 575 | 59 | 10 | int:RUVBL1 | |
| Interaction | BNC2 interactions | 6.68e-06 | 13 | 59 | 3 | int:BNC2 | |
| Interaction | NPAS2 interactions | 6.82e-06 | 42 | 59 | 4 | int:NPAS2 | |
| Interaction | SOX10 interactions | 7.32e-06 | 92 | 59 | 5 | int:SOX10 | |
| Interaction | SNRPD1 interactions | 7.35e-06 | 347 | 59 | 8 | int:SNRPD1 | |
| Interaction | SOX5 interactions | 7.79e-06 | 162 | 59 | 6 | int:SOX5 | |
| Interaction | TOX interactions | 8.48e-06 | 14 | 59 | 3 | int:TOX | |
| Interaction | ARNT interactions | 9.31e-06 | 255 | 59 | 7 | int:ARNT | |
| Interaction | SOX9 interactions | 9.49e-06 | 97 | 59 | 5 | int:SOX9 | |
| Interaction | FOXP4 interactions | 9.98e-06 | 98 | 59 | 5 | int:FOXP4 | |
| Interaction | SS18L1 interactions | 9.98e-06 | 98 | 59 | 5 | int:SS18L1 | |
| Interaction | NCOR1 interactions | 1.02e-05 | 363 | 59 | 8 | int:NCOR1 | |
| Interaction | SOX2 interactions | TRERF1 SOX6 NCOA2 SETD2 FOXP4 KMT2D TIA1 YAP1 ARID2 MITF SGO2 FOXP1 CREB1 PGK1 EP300 | 1.03e-05 | 1422 | 59 | 15 | int:SOX2 |
| Interaction | CEBPA interactions | TRERF1 NCOA2 EPC2 KMT2D HDAC4 ARID2 SF3A1 FOXP1 CREB1 CREBBP PGK1 EP300 DYNC1H1 RAD23A | 1.06e-05 | 1245 | 59 | 14 | int:CEBPA |
| Interaction | GATA1 interactions | 1.06e-05 | 171 | 59 | 6 | int:GATA1 | |
| Interaction | PPP2CA interactions | 1.07e-05 | 484 | 59 | 9 | int:PPP2CA | |
| Interaction | RUVBL2 interactions | 1.08e-05 | 616 | 59 | 10 | int:RUVBL2 | |
| Interaction | TLX1 interactions | 1.21e-05 | 175 | 59 | 6 | int:TLX1 | |
| Interaction | MED23 interactions | 1.22e-05 | 266 | 59 | 7 | int:MED23 | |
| Interaction | HDAC1 interactions | TRERF1 SOX6 KMT2D DST YAP1 SF3A1 GIGYF2 RORC RO60 CREB1 CREBBP EP300 STAT3 | 1.49e-05 | 1108 | 59 | 13 | int:HDAC1 |
| Interaction | MAML2 interactions | 1.57e-05 | 17 | 59 | 3 | int:MAML2 | |
| Interaction | FHL2 interactions | 1.91e-05 | 396 | 59 | 8 | int:FHL2 | |
| Interaction | PARP1 interactions | LZTR1 UBAP2 CHERP HDAC4 SACS YAP1 SF3A1 SGO2 BTAF1 EEA1 CREBBP PGK1 EP300 RAD23A | 1.98e-05 | 1316 | 59 | 14 | int:PARP1 |
| Interaction | SMCHD1 interactions | 1.99e-05 | 191 | 59 | 6 | int:SMCHD1 | |
| Interaction | TBR1 interactions | 1.99e-05 | 113 | 59 | 5 | int:TBR1 | |
| Interaction | SUMO1 interactions | 2.00e-05 | 287 | 59 | 7 | int:SUMO1 | |
| Interaction | MYOD1 interactions | 2.17e-05 | 194 | 59 | 6 | int:MYOD1 | |
| Interaction | SATB1 interactions | 2.26e-05 | 116 | 59 | 5 | int:SATB1 | |
| Interaction | CTBP1 interactions | 2.29e-05 | 406 | 59 | 8 | int:CTBP1 | |
| Interaction | NR2F1 interactions | 2.50e-05 | 58 | 59 | 4 | int:NR2F1 | |
| Interaction | GATA2 interactions | 2.51e-05 | 199 | 59 | 6 | int:GATA2 | |
| Interaction | ETS1 interactions | 2.77e-05 | 121 | 59 | 5 | int:ETS1 | |
| Interaction | HIC2 interactions | 3.05e-05 | 61 | 59 | 4 | int:HIC2 | |
| Interaction | PAX7 interactions | 3.12e-05 | 124 | 59 | 5 | int:PAX7 | |
| Interaction | CEBPD interactions | 3.26e-05 | 62 | 59 | 4 | int:CEBPD | |
| Interaction | NFIC interactions | 3.39e-05 | 210 | 59 | 6 | int:NFIC | |
| Interaction | PAX9 interactions | 3.92e-05 | 130 | 59 | 5 | int:PAX9 | |
| Interaction | NFYB interactions | 3.93e-05 | 65 | 59 | 4 | int:NFYB | |
| Interaction | TFDP1 interactions | 4.37e-05 | 133 | 59 | 5 | int:TFDP1 | |
| Interaction | ETV4 interactions | 4.97e-05 | 69 | 59 | 4 | int:ETV4 | |
| Interaction | YY1 interactions | 5.05e-05 | 454 | 59 | 8 | int:YY1 | |
| Interaction | KEAP1 interactions | 5.06e-05 | 332 | 59 | 7 | int:KEAP1 | |
| Interaction | BRCA1 interactions | NCOA2 UBAP2 DST SF3A1 SGO2 RO60 CLPX CREB1 CREBBP PGK1 EP300 DYNC1H1 STAT3 | 5.21e-05 | 1249 | 59 | 13 | int:BRCA1 |
| Interaction | TLE6 interactions | 5.24e-05 | 25 | 59 | 3 | int:TLE6 | |
| Interaction | FOXP2 interactions | 5.26e-05 | 70 | 59 | 4 | int:FOXP2 | |
| Interaction | SMARCA4 interactions | 5.71e-05 | 462 | 59 | 8 | int:SMARCA4 | |
| Interaction | NCOA2 interactions | 5.77e-05 | 141 | 59 | 5 | int:NCOA2 | |
| Interaction | NFIB interactions | 5.97e-05 | 142 | 59 | 5 | int:NFIB | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p13 | 1.69e-03 | 47 | 59 | 2 | chr3p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q21 | 3.02e-03 | 63 | 59 | 2 | chr11q21 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.82e-07 | 25 | 37 | 4 | 775 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.26e-06 | 17 | 37 | 3 | 486 | |
| GeneFamily | Forkhead boxes | 9.20e-05 | 43 | 37 | 3 | 508 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.11e-04 | 18 | 37 | 2 | 91 | |
| GeneFamily | SRY-boxes | 6.82e-04 | 19 | 37 | 2 | 757 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.19e-03 | 34 | 37 | 2 | 487 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 SETD2 DST HDAC4 TIA1 SACS YAP1 MITF GIGYF2 WWTR1 BTAF1 CREB1 MN1 CREBBP TMCC1 | 4.74e-10 | 856 | 59 | 15 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 SETD2 KMT2D SACS ARID2 SF3A1 EPC1 RO60 BTAF1 CREB1 CREBBP PGK1 EP300 DYNC1H1 STAT3 | 7.38e-07 | 1492 | 59 | 15 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.21e-06 | 180 | 59 | 6 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 1.16e-05 | 131 | 59 | 5 | M39232 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 3.91e-05 | 84 | 59 | 4 | M13008 | |
| Coexpression | MEDINA_SMARCA4_TARGETS | 7.34e-05 | 36 | 59 | 3 | M1554 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_UP | 8.41e-05 | 198 | 59 | 5 | M5207 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP | 8.61e-05 | 199 | 59 | 5 | M8769 | |
| Coexpression | LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B | 8.67e-05 | 103 | 59 | 4 | M39240 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.06e-04 | 208 | 59 | 5 | M39233 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 1.16e-04 | 854 | 59 | 9 | M1533 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP | 1.37e-04 | 116 | 59 | 4 | M14146 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 1.55e-04 | 888 | 59 | 9 | MM1018 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 1.67e-04 | 364 | 59 | 6 | M39057 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 1.77e-04 | 232 | 59 | 5 | M45800 | |
| Coexpression | GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP | 2.19e-04 | 131 | 59 | 4 | M8922 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | 2.24e-04 | 548 | 59 | 7 | M16859 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.83e-05 | 298 | 59 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.24e-09 | 186 | 59 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.35e-07 | 196 | 59 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-07 | 198 | 59 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.02e-06 | 156 | 59 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 158 | 59 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.74e-06 | 166 | 59 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-06 | 189 | 59 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.58e-06 | 192 | 59 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.80e-06 | 200 | 59 | 5 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.10e-05 | 135 | 59 | 4 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 162 | 59 | 4 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-05 | 165 | 59 | 4 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-05 | 165 | 59 | 4 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-05 | 165 | 59 | 4 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 7.11e-05 | 167 | 59 | 4 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 7.27e-05 | 168 | 59 | 4 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 169 | 59 | 4 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.97e-05 | 172 | 59 | 4 | 29c8510f26527d487d0fc3543102d067cdb281a6 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-05 | 176 | 59 | 4 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-05 | 176 | 59 | 4 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-05 | 177 | 59 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 182 | 59 | 4 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.03e-04 | 184 | 59 | 4 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 186 | 59 | 4 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-04 | 188 | 59 | 4 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 188 | 59 | 4 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 189 | 59 | 4 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 192 | 59 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 193 | 59 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.24e-04 | 193 | 59 | 4 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.24e-04 | 193 | 59 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 194 | 59 | 4 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 194 | 59 | 4 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-04 | 194 | 59 | 4 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 194 | 59 | 4 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-04 | 194 | 59 | 4 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 194 | 59 | 4 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-04 | 194 | 59 | 4 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 195 | 59 | 4 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 195 | 59 | 4 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.29e-04 | 195 | 59 | 4 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 196 | 59 | 4 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 196 | 59 | 4 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 196 | 59 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 196 | 59 | 4 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-04 | 197 | 59 | 4 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 200 | 59 | 4 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.42e-04 | 200 | 59 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Computational | Neighborhood of UBE2N | 1.93e-04 | 95 | 33 | 4 | MORF_UBE2N | |
| Drug | glutamin | 2.34e-06 | 461 | 58 | 9 | CID000000738 | |
| Drug | 4-Arsono-2-hydroxybutanoic acid | 6.38e-06 | 2 | 58 | 2 | CID000135804 | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A | 9.92e-06 | 194 | 58 | 6 | 2824_DN | |
| Drug | N6-Me-dAdo | 1.48e-05 | 19 | 58 | 3 | CID000168948 | |
| Drug | 4,4'-DBP | 1.48e-05 | 19 | 58 | 3 | CID000007034 | |
| Drug | Dirian | 1.91e-05 | 3 | 58 | 2 | CID003034337 | |
| Drug | AC1NDNJY | 1.91e-05 | 3 | 58 | 2 | CID004578722 | |
| Drug | AC1O5U9L | 1.91e-05 | 3 | 58 | 2 | CID006440811 | |
| Drug | stanolone benzoate | 1.91e-05 | 3 | 58 | 2 | ctd:C040109 | |
| Drug | LYR 71 | 3.81e-05 | 4 | 58 | 2 | ctd:C530478 | |
| Drug | repin | 3.81e-05 | 4 | 58 | 2 | CID000091567 | |
| Drug | MW 1 | 4.14e-05 | 151 | 58 | 5 | CID000073965 | |
| Drug | geldanamycin | 4.24e-05 | 371 | 58 | 7 | ctd:C001277 | |
| Drug | SU11274 | 4.39e-05 | 27 | 58 | 3 | CID009549297 | |
| Drug | tetrahydroaldosterone-3-glucuronide | 5.47e-05 | 29 | 58 | 3 | CID000167918 | |
| Drug | Asbestos, Crocidolite | TRERF1 DST CHERP YAP1 EPC1 MITF CCDC18 GIGYF2 MAML2 EEA1 CREB1 MAML3 | 5.64e-05 | 1241 | 58 | 12 | ctd:D017638 |
| Drug | AC1ND2OB | 5.73e-05 | 265 | 58 | 6 | CID004568637 | |
| Drug | clorsulon | 6.35e-05 | 5 | 58 | 2 | CID000043231 | |
| Drug | MF101 extract | 6.35e-05 | 5 | 58 | 2 | ctd:C517398 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 6.35e-05 | 5 | 58 | 2 | ctd:C575894 | |
| Drug | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | 7.38e-05 | 32 | 58 | 3 | ctd:C025603 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.81e-05 | 177 | 58 | 5 | 7047_DN | |
| Drug | CDVpp | 9.50e-05 | 6 | 58 | 2 | CID000501655 | |
| Drug | Ro 31-8425 | 9.50e-05 | 6 | 58 | 2 | ctd:C071924 | |
| Drug | esperamicin A1 | 9.50e-05 | 6 | 58 | 2 | CID006435576 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 9.53e-05 | 180 | 58 | 5 | 6886_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.53e-05 | 180 | 58 | 5 | 4821_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 182 | 58 | 5 | 3887_DN | |
| Drug | TCPOBOP | 1.02e-04 | 95 | 58 | 4 | CID000005382 | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 193 | 58 | 5 | 6215_DN | |
| Drug | SC-11927 | 1.33e-04 | 7 | 58 | 2 | CID003034422 | |
| Drug | ethyl octanoate | 1.33e-04 | 7 | 58 | 2 | CID000007799 | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 3783_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 4844_DN | |
| Drug | A25618 | 1.43e-04 | 777 | 58 | 9 | CID000005562 | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6941_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 7186_DN | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6231_DN | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 5874_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 6804_UP | |
| Drug | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1.56e-04 | 41 | 58 | 3 | ctd:D019307 | |
| Drug | 4-hydroxy-2-nonenal | 1.74e-04 | 798 | 58 | 9 | ctd:C027576 | |
| Drug | AC1N0FHX | 1.77e-04 | 8 | 58 | 2 | CID003916227 | |
| Drug | AC1L1EOW | 1.77e-04 | 8 | 58 | 2 | CID000002885 | |
| Drug | NSC289491 | 1.77e-04 | 8 | 58 | 2 | CID000002693 | |
| Drug | ethyl decanoate | 1.77e-04 | 8 | 58 | 2 | CID000008048 | |
| Drug | AC1L1A5Z | 1.85e-04 | 111 | 58 | 4 | CID000000850 | |
| Drug | phenethyl acetate | 2.27e-04 | 9 | 58 | 2 | CID000007654 | |
| Drug | AC1MI08J | 2.27e-04 | 9 | 58 | 2 | CID003035924 | |
| Drug | Rh(H2O)4ATP | 2.27e-04 | 9 | 58 | 2 | CID003082848 | |
| Drug | 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one | 2.27e-04 | 9 | 58 | 2 | ctd:C539142 | |
| Drug | chloroethylguanine | 2.27e-04 | 9 | 58 | 2 | CID000161383 | |
| Drug | 2-methoxy-5-nitrotropone | 2.27e-04 | 9 | 58 | 2 | CID000084563 | |
| Drug | 1 mN-9 | 2.83e-04 | 10 | 58 | 2 | CID000122108 | |
| Drug | ACVDP | 2.83e-04 | 10 | 58 | 2 | CID000501523 | |
| Drug | 25-azacoprostane | 2.83e-04 | 10 | 58 | 2 | CID000162243 | |
| Drug | DMHF | 2.83e-04 | 10 | 58 | 2 | CID003080741 | |
| Drug | bicalutamide | 2.92e-04 | 125 | 58 | 4 | CID000002375 | |
| Disease | T-Cell Lymphoma | 2.58e-08 | 16 | 59 | 4 | C0079772 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 3.03e-08 | 4 | 59 | 3 | DOID:0060038 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 1.01e-06 | 38 | 59 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.75e-06 | 100 | 59 | 5 | C0010606 | |
| Disease | Intellectual Disability | 2.94e-06 | 447 | 59 | 8 | C3714756 | |
| Disease | Menke-Hennekam syndrome | 3.93e-06 | 2 | 59 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 3.93e-06 | 2 | 59 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 3.93e-06 | 2 | 59 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.93e-06 | 2 | 59 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.93e-06 | 2 | 59 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 3.93e-06 | 2 | 59 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 3.93e-06 | 2 | 59 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 3.93e-06 | 2 | 59 | 2 | C0035934 | |
| Disease | stomach cancer (is_marker_for) | 9.77e-06 | 142 | 59 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 2.53e-05 | 173 | 59 | 5 | C0023467 | |
| Disease | Neurodevelopmental Disorders | 3.69e-05 | 93 | 59 | 4 | C1535926 | |
| Disease | Delayed speech and language development | 3.92e-05 | 5 | 59 | 2 | C0454644 | |
| Disease | Abnormality of the cerebellum | 3.92e-05 | 5 | 59 | 2 | C1866129 | |
| Disease | Phyllodes Tumor | 3.92e-05 | 5 | 59 | 2 | C0010701 | |
| Disease | Epithelioid hemangioendothelioma | 3.92e-05 | 5 | 59 | 2 | C0206732 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.92e-05 | 5 | 59 | 2 | C0600066 | |
| Disease | Central hypotonia | 5.87e-05 | 6 | 59 | 2 | C1842364 | |
| Disease | Abnormal corpus callosum morphology | 5.87e-05 | 6 | 59 | 2 | C1842581 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 6.65e-05 | 346 | 59 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Mammary Carcinoma, Human | 8.31e-05 | 525 | 59 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 8.31e-05 | 525 | 59 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 8.51e-05 | 527 | 59 | 7 | C1458155 | |
| Disease | Breast Carcinoma | 9.68e-05 | 538 | 59 | 7 | C0678222 | |
| Disease | Embryonal Rhabdomyosarcoma | 1.09e-04 | 8 | 59 | 2 | C0206656 | |
| Disease | ovarian cancer (implicated_via_orthology) | 1.09e-04 | 8 | 59 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | JT interval | 1.39e-04 | 248 | 59 | 5 | EFO_0007885 | |
| Disease | Bladder Neoplasm | 1.80e-04 | 140 | 59 | 4 | C0005695 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.85e-04 | 55 | 59 | 3 | C0079744 | |
| Disease | Malignant neoplasm of urinary bladder | 1.85e-04 | 141 | 59 | 4 | C0005684 | |
| Disease | cancer (implicated_via_orthology) | 2.00e-04 | 268 | 59 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.06e-04 | 145 | 59 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.22e-04 | 616 | 59 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.22e-04 | 616 | 59 | 7 | C0376358 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.52e-04 | 61 | 59 | 3 | C1961102 | |
| Disease | Malignant neoplasm of breast | 2.65e-04 | 1074 | 59 | 9 | C0006142 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 3.52e-04 | 14 | 59 | 2 | DOID:7474 (is_marker_for) | |
| Disease | chronotype measurement | 3.55e-04 | 882 | 59 | 8 | EFO_0008328 | |
| Disease | Lymphoma, Large-Cell, Follicular | 4.06e-04 | 15 | 59 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 4.06e-04 | 15 | 59 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 4.06e-04 | 15 | 59 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 4.06e-04 | 15 | 59 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 4.06e-04 | 15 | 59 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 4.06e-04 | 15 | 59 | 2 | C1956130 | |
| Disease | heart disease (biomarker_via_orthology) | 5.24e-04 | 17 | 59 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.34e-04 | 195 | 59 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 6.58e-04 | 19 | 59 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | QT interval | 6.83e-04 | 534 | 59 | 6 | EFO_0004682 | |
| Disease | cognitive function measurement, self reported educational attainment | 7.20e-04 | 355 | 59 | 5 | EFO_0004784, EFO_0008354 | |
| Disease | Lymphoma, Follicular | 7.30e-04 | 20 | 59 | 2 | C0024301 | |
| Disease | nevus count, cutaneous melanoma | 8.14e-04 | 91 | 59 | 3 | EFO_0000389, EFO_0004632 | |
| Disease | multisite chronic pain | 9.22e-04 | 95 | 59 | 3 | EFO_0010100 | |
| Disease | Squamous cell carcinoma of esophagus | 9.22e-04 | 95 | 59 | 3 | C0279626 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 9.68e-04 | 23 | 59 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 9.68e-04 | 23 | 59 | 2 | C1708353 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 1.05e-03 | 24 | 59 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | childhood trauma measurement | 1.05e-03 | 24 | 59 | 2 | EFO_0007979 | |
| Disease | Pancreatic Neoplasm | 1.07e-03 | 100 | 59 | 3 | C0030297 | |
| Disease | gastroesophageal reflux disease | 1.10e-03 | 101 | 59 | 3 | EFO_0003948 | |
| Disease | Malignant neoplasm of pancreas | 1.13e-03 | 102 | 59 | 3 | C0346647 | |
| Disease | Lymphatic Metastasis | 1.24e-03 | 26 | 59 | 2 | C0024232 | |
| Disease | Sezary Syndrome | 1.34e-03 | 27 | 59 | 2 | C0036920 | |
| Disease | red blood cell density measurement | 1.81e-03 | 880 | 59 | 7 | EFO_0007978 | |
| Disease | colorectal cancer (is_implicated_in) | 1.85e-03 | 121 | 59 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.88e-03 | 32 | 59 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | insomnia measurement | 1.92e-03 | 443 | 59 | 5 | EFO_0007876 | |
| Disease | non-melanoma skin carcinoma | 1.96e-03 | 265 | 59 | 4 | EFO_0009260 | |
| Disease | Squamous cell carcinoma | 1.98e-03 | 124 | 59 | 3 | C0007137 | |
| Disease | reaction time measurement | 1.99e-03 | 658 | 59 | 6 | EFO_0008393 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVNQMPTQPQVQAKN | 476 | Q09472 | |
| ALMQKQQLAQIQQQQ | 596 | Q9H2F5 | |
| VQMQRQQLAQLQQKQ | 591 | Q52LR7 | |
| QRQQLEEQKNAPMFQ | 1886 | Q15878 | |
| SMQQQVNQQIPQEKR | 256 | O76031 | |
| PTVSQMLSVKRQQQQ | 1001 | Q68CP9 | |
| VQVQVQQPQQVQMQV | 1026 | Q68CP9 | |
| LQQRILQQQQMKQQI | 2291 | Q92793 | |
| VMEKQVRSTQPQQNN | 171 | Q8IY63 | |
| QLAAQKMQVQQQQQL | 2136 | Q9C0F0 | |
| NVPMKKNQITNNQRI | 26 | P07205 | |
| RDQPQFQNMRQVIQQ | 236 | P54725 | |
| QFQQQQLQMNKIIPK | 496 | P56524 | |
| VRQQQRLLQMQQPQQ | 2056 | Q86YW9 | |
| KQNLEMNVTVQNVLQ | 761 | Q8N653 | |
| QQRAKLMQQKQQQQQ | 476 | Q96JK9 | |
| IDPNMLNTQRQQVQI | 4656 | Q03001 | |
| MRQQQPQVVEKQQET | 451 | Q76MJ5 | |
| QIVNNENPMVQQFIQ | 271 | P42263 | |
| PQVITPQQMQQILQQ | 96 | O15409 | |
| VITPQQMQQILQQQV | 106 | Q9H334 | |
| QMQQILQQQVLSPQQ | 111 | Q9H334 | |
| QQLQDLQMTKQVNNG | 211 | Q8TCJ0 | |
| QCRVQMQVVQQLEIQ | 341 | Q8IVH2 | |
| NVPMKNNQITNNQRI | 26 | P00558 | |
| QRQIMEQKQQLLLQQ | 761 | Q8IZL2 | |
| TMQQTKQQRENIQQV | 511 | Q8N573 | |
| MQEQLIQAQNTLKQN | 936 | Q15075 | |
| QKMELEQNVVLVQQQ | 1036 | B1AJZ9 | |
| QQQQQQQLAQMKLPS | 911 | Q6Y7W6 | |
| LMKALQQQQQQQQQK | 971 | Q6Y7W6 | |
| QQEEARQMQKQQQQQ | 1006 | Q6Y7W6 | |
| QVLQQLDSKRQQVQM | 826 | O14981 | |
| QQQQQQLQMPQMEAE | 336 | Q8IWX8 | |
| TLQQQQQMLQQETIR | 791 | Q5T9S5 | |
| LEQVQQQMAQNQTAP | 116 | Q9Y264 | |
| ENQQMTVQAQPQIAT | 21 | P16220 | |
| QPENTEPQNQQILQM | 441 | Q96JA4 | |
| AIQQQVANLQMKIVQ | 1231 | Q14204 | |
| RKMTQNDNQLQPIQF | 541 | Q2VIQ3 | |
| QQAQPQQTQRKMLLD | 1601 | D6RIA3 | |
| PQEQLEQVLNMLNVN | 3726 | Q9NZJ4 | |
| QQQQQRQNAALMIKQ | 546 | Q10571 | |
| LKNVNSQIRNQMVQN | 31 | Q8NEH6 | |
| NNTMREENVEPQNKQ | 11 | Q8NET4 | |
| AQQMQQQNPELIEQL | 281 | O43765 | |
| LQKQITNMYPVQQNE | 691 | Q562F6 | |
| NQMQPLNEKQIANSQ | 6 | P10155 | |
| AAIPKVMQQQQQTTQ | 111 | Q15459 | |
| MREQIQREQQQQQPH | 506 | P35712 | |
| RLQAQQNRQPLMNQI | 1196 | Q15596 | |
| QNRQPLMNQISNVSN | 1201 | Q15596 | |
| KINLLQQQIQQVNMP | 211 | Q9UN79 | |
| QPQKQVVQATAEQMR | 26 | Q5T6F2 | |
| QLQQRQQQQQEPVVK | 121 | P51449 | |
| QQQKLQAAQFMQQRV | 76 | O75030 | |
| NNQSVTRQKMQQLEQ | 191 | P40763 | |
| NQQQQMRLQQLQMEK | 301 | P46937 | |
| QTRISKMELQQQQQQ | 556 | O94876 | |
| KMELQQQQQQVVQLE | 561 | O94876 | |
| QREAQKQQQQMQNLG | 2131 | Q9BYW2 | |
| ETLDMINPVQQQNQI | 286 | P31483 | |
| MPNALTTQQQQQQKL | 221 | Q9GZV5 | |
| QRISMQEIQTQPQQI | 281 | Q96PN7 | |
| LMAEYRNKQQQQQQQ | 3591 | O14686 |